Evaluation of antipsychotic utilization among outpatient schizoprenia patients at the mental health facility in West Java

Penulis

  • Entris Sutrisno Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung, 40614, West Java, Indonesia ,
  • Nita Selifiana Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung, 40614, West Java, Indonesia ,
  • Jajang Japar Sodik Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung, 40614, West Java, Indonesia ,
  • Uvika Nurul Fajarrini Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung, 40614, West Java, Indonesia ,

DOI:

https://doi.org/10.35814/jifi.v23i1.1632

Kata Kunci:

Antipsychotic drug evaluation, Rational medicine, Schizophrenia

Abstrak

Rational use of drugs aims to give therapy according to patient’s clinical needs. Based on Ni komang's research (2021) there are still inaccuracies in the use of antipsychotic drugs. The purpose of this study was to determine the evaluation of the use of Antipsychotics based on the parameters of right indications, drugs, dosage, and frequency in outpatient schizophrenia patients at the West Java Provincial Mental Hospital. The study used a  method with descriptive presentation of data and retrospective data collection. Data obtained period October-December 2022 from 130 patients, this study evaluated the use of Antipsychotics with the parameters of right indications, drugs, dosage, and frequency then the data will be analyzed based on the criteria for drug use from Pharmacotherapy A Pathophysiologic Approach 11th and PIONAS. The results of the study on the use of Antipsychotics in schizophrenic patients at the Java Provincial Mental Hospital based on Pharmacotherapy A Pathophysiologic Approach 11th and PIONAS obtained the right indications as much as (100%), the right drugs (100%), the right dose (98%), and the right frequency (98%).

Referensi

Unduhan

Diterbitkan

2025-04-30

Terbitan

Vol 23 No 1 (2025): JIFI

Bagian

Articles

Lisensi

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.